Editorial: Transfusion management of patients with sickle cell disease: The continuing dilemma

Transfusion

Volumn 50, Issue 1, 2010, Pages 2-4

  King, Karen E ^a   Shirey, R Sue ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

BLOOD DONOR; EDITORIAL; HUMAN; INFECTION CONTROL; MEDICAL LITERATURE; MICROBIOLOGY; TRANSFUSION; VIRUS INFECTION; WORLD HEALTH ORGANIZATION; BLOOD; BLOOD TRANSFUSION; NOTE; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; HUMANS;

EID: 73649106928     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02527.x     Document Type: Editorial

References (24)

1. Tournamille C, Meunier-Costes N, Costes B, Martret J, Barrault A, Gauthier P, Zouakou R, Galacteros F, Bierling P, Noizat-Pirenne F. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion DOI: 10.1111/j.1537-2995.2009.02382.x
2. Natukunda B, Schonewille H, Ndugwa C, Brand A. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion DOI: 10.1111/j.1537-2995.2009.02435.x
3. Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997 37 : 357 61.
4. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990 : 322 : 1617 21.
5. Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, Zimring JC. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006 46 : 1526 36.
6. Platt OS. Sickle cell anemia as an inflammatory disease. J Clin Invest 2000 106 : 337 8.
7. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2004 11 : 129 51.
8. King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997 37 : 376 81.
9. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997 37 : 382 92.
10. Win N, Doughty H, Telfer P, Wild BJ, Pearson T. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001 41 : 323 8.
11. Chadebech P, Habibi A, Nzouakou R, Bachir D, Meunier-Costes N, Nonin P, Rodet M, Chami B, Galacteros F, Bierling P, Noizat-Pirenne F. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion 2009 49 : 1785 92.
12. Chaplin H Jr., Zarkowsky HS. Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med 1981 141 : 1091 3.
13. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002 42 : 37 43.
14. Osby M, Shulman IA. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients. A survey of 1182 North American laboratories. Arch Pathol Lab Med 2005 129 : 190 3.
15. Castro O, Sandler GS, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002 42 : 684 90.
16. Sakhalkar VS, Roberts K, Hawthorne LM, McCaskill DM, Veillon DM, Caldito GC, Cotelingam JD. Allosensitization in patients receiving multiple blood transfusions. Ann NY Acad Sci 2005 1054 : 495 9.
17. Ness PM. To match or not to match: the question for chronically transfused patients with sickle cell anemia. Transfusion 1994 34 : 558 61.
18. Castilho L, Rios M, Bianco C, Pellegrino J Jr., Alberto FL, Saad ST, Costa FF. DNA-based typing of blood groups for the management of multiply transfused sickle cell disease patients. Transfusion 2002 42 : 232 8.
19. Anstee DJ. Red cell genotyping and the future of pretransfusion testing. Blood 2009 114 : 248 56.
20. Garratty G. Where are we, and where are we going, with DNA-based approaches in immunohematology? Is serology finished? Transfusion 2007 47 Suppl : 1S 2S.
21. Denomme GA, Flegel WA. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008 : 48 : 2461 75.
22. Castilho L. The value of DNA analysis for antigens in the Duffy blood group system. Transfusion 2007 47 Suppl : 28S 31S.
23. Avent ND, Martinez A, Flegel WA, Olsson ML, Scott ML, Nogues N, Pisacka M, Daniels G, van der Schoot E, Muniz-Diaz E, Madgett TE, Storry JR, Beiboer SH, Maaskant-van Wijk PA, von Zabern I, Jimenez E, Tejedor D, Lopez M, Camacho E, Cheroutre G, Hacker A, Jinoch P, Svobodova I, de Haas M. The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion 2007 47 : 40S 45S.
24. Shirey RS, Boyd JS, Parwani AV, Tanz WS, Ness PM, King KE. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management. Transfusion 2002 42 : 1435 41.